ACE2 and COVID-19: Moreover, anti-TNFα (tumor necrosis factor) and Jak (Janus kinase)-inhibitors used in RA are effective for controlling ACE2 expression, which may contribute to prevention of infections and/or severe forms induced by COVID-19 [17,18].